Light therapy, also known as phototherapy, is a valuable treatment option for various chronic skin conditions. This therapy involves exposing the skin to specific wavelengths of ultraviolet (UV) light to alleviate symptoms and improve skin health.
For chronic conditions like psoriasis and eczema, phototherapy, particularly narrowband UVB (NB-UVB) light, has been proven effective. NB-UVB light slows down the rapid skin cell growth associated with these conditions, reducing inflammation and scaling. Decades of use have demonstrated that regular treatments can lead to significant improvement in skin clarity and reduce the frequency of painful, embarrassing flare-ups.
Vitiligo, a chronic condition causing loss of skin color, can also benefit from light therapy. In this case, UVB light therapy can stimulate the production of melanin, the pigment responsible for skin color. By targeting specific areas of the skin, this therapy can help re-pigment affected areas and restore a more even skin tone.
The Zerigo Skin Health Program is reinventing treatment for chronic skin conditions like Atopic dermatitis by harnessing the proven power of narrowband UVB phototherapy in a portable, handheld device1 backed by a holistic care program – at no cost to you1.
Free yourself from the pain and disruption of living with a chronic skin condition. The Zerigo Skin Health Program makes treatment painless, hassle-free, and convenient from anywhere, at any time that works for you.
Your skin condition is unique to you. That’s why every Zerigo treatment plan is tailored to meet you where you are today and get you on the road to clearer skin—fast.
Break the trial-and-error treatment cycle. Used as a standalone treatment or in combination with advanced therapies, narrowband UVB phototherapy is a proven approach2 to deliver maximum clearance without the side effects.
Zerigo members can’t stop talking about their results.
1The Zerigo Health Phototherapy System is an ultraviolet-light-emitting medical device. It is intended for use in localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma on all skin types (I-VI). The device can be used in the comfort of a patient’s home or in a physician’s office. Individual results may vary. U.S. federal law restricts this device to sale by or on the order of a physician.
2See, e.g., Elmets CA, et al., Joint American Academy of Dermatology: National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy, 2019 Sep;81(3):775-804; Myers E, Kheradmand S, Miller R. An Update on Narrowband Ultraviolet B Therapy for the Treatment of Skin Diseases. Cureus. 2021 Nov 1;13(11):e19182.
3Springer Dermatological Research; Adjunctive Treatment of Atopic Dermatitis with Novel At-Home Handheld Narrow-Band UVB Phototherapy
4The Zerigo Health Solution is available through your healthcare benefits as a value-added service. You may have to pay a copay or coinsurance if you see your doctor to get a prescription for phototherapy treatment.
5Zerigo Care Guides include RNs, MAs, and certified health and wellness coaches who can help coordinate and facilitate your discussion with your doctor. The Care Guides do not prescribe therapies or provide patient-specific medical advice. For questions about your prescription or treatment plan, please contact your doctor.
6Offered in conjunction with independent virtual care provider, CirrusMD.
7Cutis, Phototherapy: Safe and Effective for Chronic skin conditions in older adults
8Zerigo Health member survey, conducted May 2020
9Springer Dermatological Research; Adjunctive Treatment of Atopic Dermatitis with Novel At-Home Handheld Narrow-Band UVB Phototherapy
10Journal of Dermatological Treatment; Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies
11Journal of Drugs in Dermatology; The Impact of At-Home Narrow-Band UVB Phototherapy for Mild-to-Severe Psoriasis
12Based on third party actuarial data on chronic skin condition advanced therapy costs among 30 million commercial plan members
13Estimated average return on investment (ROI) for commercial member with psoriasis. In analysis of claims cost of 30 million commercial health plan members, projected ROI vary from 3x-15x depending on diagnosis and advanced therapies used.
14One year pilot with large national PBM conducted with commercial health plan members
15CirrusMD website
16Danesh et al, 2015 and Anderson et al, 2015
17Journal of Managed Care & Specialty Pharmacy, The Direct and Indirect Costs of Atopic Dermatitis
18National Institutes of Health, Burden of Atopic Dermatitis in Adults and Adolescents